Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/38951
Full metadata record
DC FieldValueLanguage
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorZINZANI, P. L.
dc.contributor.authorRAMCHANDREN, R.
dc.contributor.authorSANTORO, A.
dc.contributor.authorPASZKIEWICZ-KOZIK, E.
dc.contributor.authorGASIOROWSKI, R.
dc.contributor.authorJOHNSON, N. A.
dc.contributor.authorOLIVEIRA, J. S. R. de
dc.contributor.authorBUCCHERI, V.
dc.contributor.authorPERINI, G. F.
dc.contributor.authorDICKINSON, M.
dc.contributor.authorMCDONALD, A.
dc.contributor.authorOZCAN, M.
dc.contributor.authorSEKIGUCHI, N.
dc.contributor.authorRAUT, M.
dc.contributor.authorZHU, Y.
dc.contributor.authorNAHAR, A.
dc.contributor.authorMARINELLO, P.
dc.contributor.authorKURUVILLA, J.
dc.date.accessioned2021-01-25T19:34:13Z-
dc.date.available2021-01-25T19:34:13Z-
dc.date.issued2020
dc.identifier.citationANNALS OF ONCOLOGY, v.31, suppl.4, p.S649-S649, 2020
dc.identifier.issn0923-7534
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/38951-
dc.description.sponsorshipMerck Sharp Dohme Corp.Merck & Company
dc.language.isoeng
dc.publisherELSEVIEReng
dc.relation.ispartofAnnals of Oncology
dc.rightsrestrictedAccesseng
dc.titleHealth-related quality of life (HRQoL) from KEYNOTE-204: A phase III, randomized, open-label study of pembrolizumab (pembro) vs brentuximab vedotin (BV) in relapsed or refractory classical Hodgkin lymphoma (R/R cHL)eng
dc.typeconferenceObjecteng
dc.rights.holderCopyright ELSEVIEReng
dc.description.conferencedateSEP 19-OCT 18, 2020
dc.description.conferencelocalELECTR NETWORK
dc.description.conferencenameESMO Virtual Congress
dc.identifier.doi10.1016/j.annonc.2020.08.004
dc.subject.wosOncologyeng
dc.type.categorymeeting abstracteng
dc.type.versionpublishedVersioneng
hcfmusp.author.externalZINZANI, P. L.:Univ Bologna, Inst Hematol LeA Seragnoli, Expt Diagnost & Specialty Med, Bologna, Italy
hcfmusp.author.externalRAMCHANDREN, R.:Univ Tennessee, Med, Knoxville, TN USA
hcfmusp.author.externalSANTORO, A.:Humanitas Canc Ctr, Oncol, Milan, Italy
hcfmusp.author.externalPASZKIEWICZ-KOZIK, E.:Maria Sklodowska Curie Natl Inst Oncol, Med Oncol, Warsaw, Poland
hcfmusp.author.externalGASIOROWSKI, R.:Univ Sydney, Concord Hosp, Hematol, Sydney, NSW, Australia
hcfmusp.author.externalJOHNSON, N. A.:Jewish Gen Hosp, Hematol, Montreal, PQ, Canada
hcfmusp.author.externalOLIVEIRA, J. S. R. de:Casa Saude Santa Marcelina, Med Oncol, Sao Paulo, Brazil
hcfmusp.author.externalPERINI, G. F.:Hosp Israelita Albert Einstein, Hematol, Sao Paulo, Brazil
hcfmusp.author.externalDICKINSON, M.:Peter MacCallum Canc Ctr, Lymphoma Dis, Melbourne, Vic, Australia; Royal Melbourne Hosp, Melbourne, Vic, Australia
hcfmusp.author.externalMCDONALD, A.:Pretoria East Hosp, Hematol, Pretoria, South Africa
hcfmusp.author.externalOZCAN, M.:Ankara Univ, Tip Fak, Internal Med, Ankara, Turkey
hcfmusp.author.externalSEKIGUCHI, N.:Natl Hosp Org Disaster Med Ctr, Med Oncol, Tokyo, Japan
hcfmusp.author.externalRAUT, M.:Merck & Co Inc, Med Oncol, Kenilworth, NJ USA
hcfmusp.author.externalZHU, Y.:Merck & Co Inc, Med Oncol, Kenilworth, NJ USA
hcfmusp.author.externalNAHAR, A.:Merck & Co Inc, Med Oncol, Kenilworth, NJ USA
hcfmusp.author.externalMARINELLO, P.:Merck & Co Inc, Med Oncol, Kenilworth, NJ USA
hcfmusp.author.externalKURUVILLA, J.:Princess Margaret Canc Ctr, Med Oncol & Hematol, Toronto, ON, Canada
hcfmusp.description.beginpageS649
hcfmusp.description.endpageS649
hcfmusp.description.issuesuppl 4
hcfmusp.description.volume31
hcfmusp.origemWOS
hcfmusp.origem.idWOS:000573469101174
hcfmusp.publisher.cityAMSTERDAMeng
hcfmusp.publisher.countryNETHERLANDSeng
dc.description.indexMEDLINEeng
dc.identifier.eissn1569-8041
Appears in Collections:

Comunicações em Eventos - HC/ICHC
Instituto Central - HC/ICHC


Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.